In adults with narcolepsy type 1 (NT1), a specific brain region called the hypothalamus is smaller than in people without the condition, according to a new study. The findings add to a body of…

Alkermes has launched the Brilliance Studies, a Phase 3 clinical trial program that will evaluate the safety and effectiveness of alixorexton, its once-daily oral therapy candidate for people with narcolepsy types 1…

Modafinil, sold under the brand name Provigil among others, significantly eases excessive daytime sleepiness in people with narcolepsy, according to a new systematic review and meta-analysis. Across more than a half dozen…